Recommendations around dosing, duration, and patient-specific options are woven into the fabric of the scientific statement.

Treatment with apixaban (Eliquis, Bristol-Myers Squibb/Pfizer), regardless of dosage, was associated with significantly less major bleeding compared with warfarin in a particularly high-risk ...

Apixaban 0.15mg; pwd for oral susp in caps. Apixaban is an oral, reversible, and selective active site inhibitor of FXa. It does not require antithrombin III for antithrombotic activity. Apixaban ...

Please provide your email address to receive an email when new articles are posted on . Apixaban dose reduction to 2.5 mg twice daily appeared safe after 6 months of full-dose treatment for venous ...

Please provide your email address to receive an email when new articles are posted on . Label-concordant dosing may benefit patients on dialysis with nonvalvular atrial fibrillation more than ...

In patients with non-valvular atrial fibrillation (NVAF), no significant difference was seen in the risk of ischaemic stroke/systemic embolism (IS/SE) between those ...

Dear Dr. Roach: I take Eliquis. I have no stomach; it was totally removed as a preventative measure due to the risk of stomach cancer. So, I have been trying to find out how much of this expensive ...

Eliquis 360 Support Program Now Offers Eliquis to Cash-Paying Patients at More than 40% Discount to Current List Price Beginning September 8, eligible U.S. patients with an Eliquis prescription may ...

Eliquis 360 Support Program Now Offers Eliquis to Cash-Paying Patients at More than 40% Discount to Current List Price PRINCETON, N.J.--(BUSINESS WIRE)-- The Bristol Myers Squibb-Pfizer (BMS NYSE: BMY ...